Patricia J Miyake

Title: Innovations of Patricia J Miyake

Introduction

Patricia J Miyake is a notable inventor based in Tower Lakes, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of enhanced formulations of the drug celecoxib. With a total of 2 patents, her work has the potential to improve the bioavailability of important medications.

Latest Patents

Miyake's latest patents focus on the solid-state form of celecoxib, which is a selective cyclooxygenase-2 inhibitory drug. This innovative formulation is provided in an amorphous state, which enhances its bioavailability. The patents detail a celecoxib drug substance that includes amorphous celecoxib in detectable amounts. Additionally, her work includes the development of a celecoxib-crystallization inhibitor composite, which comprises particles of amorphous celecoxib in association with crystallization inhibitors, such as polymers. The patents also describe processes for preparing these formulations and methods for treating medical conditions where cyclooxygenase-2 inhibitors are indicated.

Career Highlights

Throughout her career, Patricia J Miyake has worked with prominent companies, including Pharmacia Corporation and Pfizer, Inc. Her experience in these organizations has allowed her to collaborate with leading professionals in the pharmaceutical industry.

Collaborations

Some of her notable coworkers include Michael J Hageman and Xiaorong He. Their collective expertise has contributed to the advancement of innovative pharmaceutical solutions.

Conclusion

Patricia J Miyake's contributions to the field of pharmaceuticals, particularly through her patents on celecoxib formulations, highlight her role as a significant inventor. Her work continues to pave the way for advancements in drug delivery and treatment options.